ALEMBIC PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]
ALEMBIC PHARMACEUTICALS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,770 Cr | ₹1,693 Cr | ₹1,648 Cr | ₹1,562 Cr | ₹1,517 Cr | ₹1,631 Cr | ₹1,595 Cr | ₹1,486 Cr |
Expenses | ₹1,498 Cr | ₹1,433 Cr | ₹1,409 Cr | ₹1,325 Cr | ₹1,257 Cr | ₹1,364 Cr | ₹1,387 Cr | ₹1,287 Cr |
Operating Income | ₹272 Cr | ₹260 Cr | ₹239 Cr | ₹237 Cr | ₹260 Cr | ₹266 Cr | ₹208 Cr | ₹199 Cr |
Other Income | ₹14 Cr | ₹10 Cr | ₹17 Cr | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹10 Cr | ₹12 Cr |
Interest | ₹25 Cr | ₹22 Cr | ₹19 Cr | ₹13 Cr | ₹11 Cr | ₹15 Cr | ₹16 Cr | ₹14 Cr |
Depreciation | ₹69 Cr | ₹70 Cr | ₹71 Cr | ₹69 Cr | ₹69 Cr | ₹69 Cr | ₹68 Cr | ₹66 Cr |
Profit Before Tax | ₹193 Cr | ₹177 Cr | ₹180 Cr | ₹157 Cr | ₹183 Cr | ₹185 Cr | ₹135 Cr | ₹130 Cr |
Profit After Tax | ₹157 Cr | ₹137 Cr | ₹152 Cr | ₹134 Cr | ₹179 Cr | ₹181 Cr | ₹137 Cr | ₹121 Cr |
EPS | ₹7.98 | ₹7.04 | ₹7.81 | ₹6.85 | ₹9.07 | ₹9.18 | ₹6.95 | ₹6.14 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALEMBIC PHARMACEUTICALS | -2.6% | -5.6% | 8.8% |
SUN PHARMACEUTICAL INDUSTRIES | -2.5% | -4.7% | 11.9% |
DIVIS LABORATORIES | -2.7% | -0.7% | 50.4% |
CIPLA | -1.2% | 0.8% | -0.9% |
TORRENT PHARMACEUTICALS | 1.4% | -1.5% | 13.3% |
DR REDDYS LABORATORIES | -2.3% | 8.2% | 11.1% |
MANKIND PHARMA | -1.1% | -8.1% | 6.5% |
ZYDUS LIFESCIENCES | -2% | 5.2% | -11.2% |
LUPIN | -4.2% | -4.2% | 25.2% |
ALEMBIC PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.54 % |
Y-o-Y | 16.66 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹1,770 Cr | 4.54 | |
Dec2024 | ₹1,693 Cr | 2.72 | |
Sep2024 | ₹1,648 Cr | 5.52 | |
Jun2024 | ₹1,562 Cr | 2.95 | |
Mar2024 | ₹1,517 Cr | -6.97 | |
Dec2023 | ₹1,631 Cr | 2.23 | |
Sep2023 | ₹1,595 Cr | 7.32 | |
Jun2023 | ₹1,486 Cr | - |
ALEMBIC PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 4.50 % |
Y-o-Y | 4.57 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹272 Cr | 4.50 | |
Dec2024 | ₹260 Cr | 8.76 | |
Sep2024 | ₹239 Cr | 1.03 | |
Jun2024 | ₹237 Cr | -8.93 | |
Mar2024 | ₹260 Cr | -2.37 | |
Dec2023 | ₹266 Cr | 27.91 | |
Sep2023 | ₹208 Cr | 4.80 | |
Jun2023 | ₹199 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 0.00 % |
Y-o-Y | -10.33 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 15.37% | 0.00 | |
Dec2024 | 15.37% | 5.85 | |
Sep2024 | 14.52% | -4.22 | |
Jun2024 | 15.16% | -11.55 | |
Mar2024 | 17.14% | 4.90 | |
Dec2023 | 16.34% | 25.11 | |
Sep2023 | 13.06% | -2.32 | |
Jun2023 | 13.37% | - |
ALEMBIC PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 14.53 % |
Y-o-Y | -11.93 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹157 Cr | 14.53 | |
Dec2024 | ₹137 Cr | -9.81 | |
Sep2024 | ₹152 Cr | 13.46 | |
Jun2024 | ₹134 Cr | -24.85 | |
Mar2024 | ₹179 Cr | -1.05 | |
Dec2023 | ₹181 Cr | 31.68 | |
Sep2023 | ₹137 Cr | 13.63 | |
Jun2023 | ₹121 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 9.62 % |
Y-o-Y | -24.47 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 8.89 % | 9.62 | |
Dec2024 | 8.11 % | -12.23 | |
Sep2024 | 9.24 % | 7.57 | |
Jun2024 | 8.59 % | -27.02 | |
Mar2024 | 11.77 % | 6.32 | |
Dec2023 | 11.07 % | 28.87 | |
Sep2023 | 8.59 % | 5.79 | |
Jun2023 | 8.12 % | - |
ALEMBIC PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 13.35 % |
Y-o-Y | -12.02 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹7.98 | 13.35 | |
Dec2024 | ₹7.04 | -9.86 | |
Sep2024 | ₹7.81 | 14.01 | |
Jun2024 | ₹6.85 | -24.48 | |
Mar2024 | ₹9.07 | -1.20 | |
Dec2023 | ₹9.18 | 32.09 | |
Sep2023 | ₹6.95 | 13.19 | |
Jun2023 | ₹6.14 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD